HPV Type Replacement After HPV Vaccination
- 16 February 2026
- book chapter
- Published by Springer Nature
- Vol. 448, 113-127
Abstract
Human papillomavirus (HPV) vaccination effectively reduces the risk of HPV-attributable cancers, including cervical, vulvar, vaginal, anal, oropharyngeal, and other head and neck cancers. Concerns for a lower-than-expected vaccine impact, as defined as an increase in the prevalence of precancer by nonvaccine types, compared to that anticipated based on attribution studies, have been raised in the postvaccination era. Three distinct and nonmutually exclusive processes—HPV type replacement, clinical unmasking, and viral unmasking—could be responsible for this apparent increase of nonvaccine types. HPV type replacement, in which nonvaccine types fill a niche left vacant after the elimination of vaccine types, is unlikely to occur due to the remarkable genetic stability of the virus and the lack of natural competition between individual HPV types. However, clinical unmasking, in which the absence of clinical interventions aimed at eliminating cervical disease caused by vaccine types permits uninterrupted progression of nonvaccine types, may occur since HPV coinfections are common. Alternatively, the observed shift could be completely erroneous due to the false discovery of type replacement via viral unmasking, a diagnostic assay artifact. In this chapter, we describe these processes and the mechanisms underlying them.Keywords
This publication has 78 references indexed in Scilit:
- International Anal Neoplasia Society's consensus guidelines for anal cancer screeningInternational Journal of Cancer, 2024
- Long‐term follow‐up of human papillomavirus type replacement among young pregnant Finnish females before and after a community‐randomised HPV vaccination trial with moderate coverageInternational Journal of Cancer, 2020
- Identification of HPV genotypes causing cervical precancer using tissue‐based genotypingInternational Journal of Cancer, 2020
- One virus, one lesion—individual components of CIN lesions contain a specific HPV typeThe Journal of Pathology, 2011
- Author's reply to: Multiple human papillomavirus genotype infections in cervical cancer progression in the study to understand cervical cancer early endpoints and determinantsInternational Journal of Cancer, 2010
- Predicting the progression of cervical precursor lesions by human papillomavirus genotyping: A prospective cohort studyInternational Journal of Cancer, 2010
- Multiple human papillomavirus genotype infections in cervical cancer progression in the study to understand cervical cancer early endpoints and determinantsInternational Journal of Cancer, 2009
- Genome variation of human papillomavirus types: Phylogenetic and medical implicationsInternational Journal of Cancer, 2005
- Biases in human papillomavirus genotype prevalence assessment associatedwith commonly used consensus primersInternational Journal of Cancer, 2005
- Papillomavirus-like particles and HPV vaccine developmentSeminars in Cancer Biology, 1996